Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 3528274, 13 pages
http://dx.doi.org/10.1155/2016/3528274
Research Article

Protective Effects of Melatonin on Retinal Inflammation and Oxidative Stress in Experimental Diabetic Retinopathy

1Department of Ophthalmology, Eye and ENT Hospital, Fudan University, Shanghai 200031, China
2Shanghai Key Laboratory of Visual Impairment and Restoration, Shanghai 200031, China
3Department of Ophthalmology, University of Texas Medical Branch, Galveston, TX 77555, USA

Received 9 December 2015; Revised 14 March 2016; Accepted 17 March 2016

Academic Editor: Francisco J. Romero

Copyright © 2016 Tingting Jiang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. N. Frank, “Diabetic retinopathy,” The New England Journal of Medicine, vol. 350, no. 1, pp. 48–58, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Williams, M. Airey, H. Baxter, J. Forrester, T. Kennedy-Martin, and A. Girach, “Epidemiology of diabetic retinopathy and macular oedema: a systematic review,” Eye, vol. 18, no. 10, pp. 963–983, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. R. A. Kowluru and P.-S. Chan, “Oxidative stress and diabetic retinopathy,” Experimental Diabesity Research, vol. 2007, Article ID 43603, 12 pages, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Tang and T. S. Kern, “Inflammation in diabetic retinopathy,” Progress in Retinal and Eye Research, vol. 30, no. 5, pp. 343–358, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. A. J. Augustin, A. Keller, F. Koch, B. Jurklies, and B. Dick, “Effect of retinal coagulation status on oxidative metabolite and VEGF in 208 patients with proliferative diabetic retinopathy,” Klinische Monatsblätter für Augenheilkunde, vol. 218, no. 2, pp. 89–94, 2001. View at Publisher · View at Google Scholar
  6. D. Bonnefont-Rousselot and F. Collin, “Melatonin: action as antioxidant and potential applications in human disease and aging,” Toxicology, vol. 278, no. 1, pp. 55–67, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Galano, D. X. Tan, and R. J. Reiter, “Melatonin as a natural ally against oxidative stress: a physicochemical examination,” Journal of Pineal Research, vol. 51, no. 1, pp. 1–16, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Galano, D. X. Tan, and R. J. Reiter, “On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK,” Journal of Pineal Research, vol. 54, no. 3, pp. 245–257, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Romero, E. Ramos, C. de Los Ríos, J. Egea, J. Del Pino, and R. J. Reiter, “A review of metal-catalyzed molecular damage: protection by melatonin,” Journal of Pineal Research, vol. 56, no. 4, pp. 343–370, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Agil, R. J. Reiter, A. Jiménez-Aranda et al., “Melatonin ameliorates low-grade inflammation and oxidative stress in young Zucker diabetic fatty rats,” Journal of Pineal Research, vol. 54, no. 4, pp. 381–388, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Negi, A. Kumar, and S. S. Sharma, “Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-κB and Nrf2 cascades,” Journal of Pineal Research, vol. 50, no. 2, pp. 124–131, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. J. L. Mauriz, P. S. Collado, C. Veneroso, R. J. Reiter, and J. González-Gallego, “A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives,” Journal of Pineal Research, vol. 54, no. 1, pp. 1–14, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. X. Liu, Y. Gong, K. Xiong et al., “Melatonin mediates protective effects on inflammatory response induced by interleukin-1 beta in human mesenchymal stem cells,” Journal of Pineal Research, vol. 55, no. 1, pp. 14–25, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Kanter, H. Uysal, T. Karaca, and H. O. Sagmanligil, “Depression of glucose levels and partial restoration of pancreatic β-cell damage by melatonin in streptozotocin-induced diabetic rats,” Archives of Toxicology, vol. 80, no. 6, pp. 362–369, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. R. A. Derlacz, P. Poplawski, M. Napierala, A. K. Jagielski, and J. Bryla, “Melatonin-induced modulation of glucose metabolism in primary cultures of rabbit kidney-cortex tubules,” Journal of Pineal Research, vol. 38, no. 3, pp. 164–169, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Guven, O. Yavuz, M. Cam et al., “Effects of melatonin on streptozotocin-induced diabetic liver injury in rats,” Acta Histochemica, vol. 108, no. 2, pp. 85–93, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Gül, S. Emre, M. Eşrefoğlu, and N. Vard, “Protective effects of melatonin and aminoguanidine on the cornea in streptozotocin-induced diabetic rats,” Cornea, vol. 27, no. 7, pp. 795–801, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Tosini and M. Menaker, “The clock in the mouse retina: melatonin synthesis and photoreceptor degeneration,” Brain Research, vol. 789, no. 2, pp. 221–228, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. D. do Carmo Buonfiglio, R. A. Peliciari-Garcia, F. G. do Amaral et al., “Early-stage retinal melatonin synthesis impairment in streptozotocin-induced diabetic wistar rats,” Investigative Ophthalmology and Visual Science, vol. 52, no. 10, pp. 7416–7422, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Gürpinar, N. Ekerbiçer, N. Uysal, T. Barut, F. Tarakçi, and M. I. Tuglu, “The effects of the melatonin treatment on the oxidative stress and apoptosis in diabetic eye and brain,” TheScientificWorldJournal, vol. 2012, Article ID 498489, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Jiang, Q. Chang, Z. Zhao et al., “Melatonin-mediated cytoprotection against hyperglycemic injury in Müller cells,” PLoS ONE, vol. 7, no. 12, Article ID e50661, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. R. B. Caldwell, M. Bartoli, M. A. Behzadian et al., “Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives,” Diabetes/Metabolism Research and Reviews, vol. 19, no. 6, pp. 442–455, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. S. A. Madsen-Bouterse and R. A. Kowluru, “Oxidative stress and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives,” Reviews in Endocrine and Metabolic Disorders, vol. 9, no. 4, pp. 315–327, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Rodriguez, J. C. Mayo, R. M. Sainz et al., “Regulation of antioxidant enzymes: a significant role for melatonin,” Journal of Pineal Research, vol. 36, no. 1, pp. 1–9, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Özdemir, Y. Ergün, S. Bakariş, M. Kılınç, H. Durdu, and E. Ganiyusufoğlu, “Melatonin prevents retinal oxidative stress and vascular changes in diabetic rats,” Eye, vol. 28, no. 8, pp. 1020–1027, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. E. M. Salido, M. Bordone, A. De Laurentiis et al., “Therapeutic efficacy of melatonin in reducing retinal damage in an experimental model of early type 2 diabetes in rats,” Journal of Pineal Research, vol. 54, no. 2, pp. 179–189, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. K. H. Jung, S.-W. Hong, H.-M. Zheng, D.-H. Lee, and S.-S. Hong, “Melatonin downregulates nuclear erythroid 2-related factor 2 and nuclear factor-kappaB during prevention of oxidative liver injury in a dimethylnitrosamine model,” Journal of Pineal Research, vol. 47, no. 2, pp. 173–183, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. R. J. Reiter, D.-X. Tan, C. Osuna, and E. Gitto, “Actions of melatonin in the reduction of oxidative stress. A review,” Journal of Biomedical Science, vol. 7, no. 6, pp. 444–458, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Leon, D. Acuña-Castroviejo, R. M. Sainz, J. C. Mayo, D.-X. Tan, and R. J. Reiter, “Melatonin and mitochondrial function,” Life Sciences, vol. 75, no. 7, pp. 765–790, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. R. L. Engerman and T. S. Kern, “Retinopathy in animal models of diabetes,” Diabetes/Metabolism Reviews, vol. 11, no. 2, pp. 109–120, 1995. View at Publisher · View at Google Scholar · View at Scopus
  31. I. G. Obrosova, A. G. Minchenko, R. Vasupuram et al., “Aldose reductase inhibitor fidarestat prevents retinal oxidative stress and vascular endothelial growth factor overexpression in streptozotocin-diabetic rats,” Diabetes, vol. 52, no. 3, pp. 864–871, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. N. Kato, S. Yashima, T. Suzuki, Y. Nakayama, and T. Jomori, “Long-term treatment with fidarestat suppresses the development of diabetic retinopathy in STZ-induced diabetic rats,” Journal of Diabetes and Its Complications, vol. 17, no. 6, pp. 374–379, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. S. P. Ayalasomayajula and U. B. Kompella, “Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model,” European Journal of Pharmacology, vol. 458, no. 3, pp. 283–289, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. Q. Li, E. Zemel, B. Miller, and I. Perlman, “Early retinal damage in experimental diabetes: electroretinographical and morphological observations,” Experimental Eye Research, vol. 74, no. 5, pp. 615–625, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Agil, I. Rosado, R. Ruiz, A. Figueroa, N. Zen, and G. Fernández-Vázquez, “Melatonin improves glucose homeostasis in young Zucker diabetic fatty rats,” Journal of Pineal Research, vol. 52, no. 2, pp. 203–210, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. M. M. Anwar and A.-R. M. A. Meki, “Oxidative stress in streptozotocin-induced diabetic rats: effects of garlic oil and melatonin,” Comparative Biochemistry and Physiology—A Molecular and Integrative Physiology, vol. 135, no. 4, pp. 539–547, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. A. K. Natesan and V. M. Cassone, “Melatonin receptor mRNA localization and rhythmicity in the retina of the domestic chick, Gallus domesticus,” Visual Neuroscience, vol. 19, no. 3, pp. 265–274, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Sengupta, K. Baba, F. Mazzoni et al., “Localization of Melatonin receptor 1 in mouse retina and its role in the circadian regulation of the electroretinogram and dopamine levels,” PLoS ONE, vol. 6, no. 9, Article ID e24483, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. A. F. Wiechmann and J. A. Summers, “Circadian rhythms in the eye: the physiological significance of melatonin receptors in ocular tissues,” Progress in Retinal and Eye Research, vol. 27, no. 2, pp. 137–160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. A. M. Mathes, D. Kubulus, J. Weiler et al., “Melatonin receptors mediate improvements of liver function but not of hepatic perfusion and integrity after hemorrhagic shock in rats,” Critical Care Medicine, vol. 36, no. 1, pp. 24–29, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Das, M. McDowell, M. J. Pava et al., “The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-α toxicity involves membrane melatonin receptors,” Journal of Pineal Research, vol. 48, no. 2, pp. 157–169, 2010. View at Publisher · View at Google Scholar · View at Scopus
  42. T. W. Kensler, N. Wakabayashi, and S. Biswal, “Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway,” Annual Review of Pharmacology and Toxicology, vol. 47, pp. 89–116, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. J. Y. Chan and M. Kwong, “Impaired expression of glutathione synthetic enzyme genes in mice with targeted deletion of the Nrf2 basic-leucine zipper protein,” Biochimica et Biophysica Acta (BBA)—Gene Structure and Expression, vol. 1517, no. 1, pp. 19–26, 2000. View at Publisher · View at Google Scholar · View at Scopus
  44. R. T. Mulcahy, M. A. Wartman, H. H. Bailey, and J. J. Gipp, “Constitutive and β-naphthoflavone-induced expression of the human γ-glutamylcysteine synthetase heavy subunit gene is regulated by a distal antioxidant response element/TRE sequence,” Journal of Biological Chemistry, vol. 272, no. 11, pp. 7445–7454, 1997. View at Publisher · View at Google Scholar · View at Scopus
  45. Q. Zhong, M. Mishra, and R. A. Kowluru, “Transcription factor Nrf2-mediated antioxidant defense system in the development of diabetic retinopathy,” Investigative Ophthalmology and Visual Science, vol. 54, no. 6, pp. 3941–3948, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. L. Wang, Y. Chen, P. Sternberg, and J. Cai, “Essential roles of the PI3 kinase/Akt pathway in regulating Nrf2-dependent antioxidant functions in the RPE,” Investigative Ophthalmology and Visual Science, vol. 49, no. 4, pp. 1671–1678, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Papaiahgari, Q. Zhang, S. R. Kleeberger, H.-Y. Cho, and S. P. Reddy, “Hyperoxia stimulates an Nrf2-ARE transcriptional response via ROS-EGFR-P13K-Akt/ERK MAP kinase signaling in pulmonary epithelial cells,” Antioxidants and Redox Signaling, vol. 8, no. 1-2, pp. 43–52, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. X. Xi, L. Gao, D. A. Hatala et al., “Chronically elevated glucose-induced apoptosis is mediated by inactivation of Akt in cultured Müller cells,” Biochemical and Biophysical Research Communications, vol. 326, no. 3, pp. 548–553, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. Y.-H. Kim, Y.-S. Kim, C.-H. Park et al., “Protein kinase C-δ mediates neuronal apoptosis in the retinas of diabetic rats via the akt signaling pathway,” Diabetes, vol. 57, no. 8, pp. 2181–2190, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Murata, T. Ishibashi, A. Khalil, Y. Hata, H. Yoshikawa, and H. Inomata, “Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels,” Ophthalmic Research, vol. 27, no. 1, pp. 48–52, 1995. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Qaum, Q. Xu, A. M. Joussen et al., “VEGF-initiated blood-retinal barrier breakdown in early diabetes,” Investigative Ophthalmology and Visual Science, vol. 42, no. 10, pp. 2408–2413, 2001. View at Google Scholar · View at Scopus
  52. A. P. Adamis, J. W. Miller, M.-T. Bernal et al., “Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy,” American Journal of Ophthalmology, vol. 118, no. 4, pp. 445–450, 1994. View at Publisher · View at Google Scholar · View at Scopus
  53. C. Kaur, V. Sivakumar, Z. Yong, J. Lu, W. S. Foulds, and E. A. Ling, “Blood-retinal barrier disruption and ultrastructural changes in the hypoxic retina in adult rats: the beneficial effect of melatonin administration,” The Journal of Pathology, vol. 212, no. 4, pp. 429–439, 2007. View at Publisher · View at Google Scholar · View at Scopus
  54. A. M. Joussen, V. Poulaki, M. L. Le et al., “A central role for inflammation in the pathogenesis of diabetic retinopathy,” The FASEB Journal, vol. 18, no. 12, pp. 1450–1452, 2004. View at Publisher · View at Google Scholar · View at Scopus
  55. A. Gverović Antunica, K. Karaman, L. Znaor, A. Sapunar, V. Buško, and V. Puzović, “IL-12 concentrations in the aqueous humor and serum of diabetic retinopathy patients,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 250, no. 6, pp. 815–821, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. J. Zhou, S. Wang, and X. Xia, “Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy,” Current Eye Research, vol. 37, no. 5, pp. 416–420, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. P. H. Sande, D. Dorfman, D. C. Fernandez et al., “Treatment with melatonin after onset of experimental uveitis attenuates ocular inflammation,” British Journal of Pharmacology, vol. 171, no. 24, pp. 5696–5707, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Karin, Y. Yamamoto, and Q. M. Wang, “The IKK NF-κB system: a treasure trove for drug development,” Nature Reviews Drug Discovery, vol. 3, no. 1, pp. 17–26, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. N. Nagai, K. Izumi-Nagai, Y. Oike et al., “Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-κB pathway,” Investigative Ophthalmology and Visual Science, vol. 48, no. 9, pp. 4342–4350, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. P. H. Sande, D. C. Fernandez, H. J. Aldana Marcos et al., “Therapeutic effect of melatonin in experimental uveitis,” The American Journal of Pathology, vol. 173, no. 6, pp. 1702–1713, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. R. Medeiros, R. D. S. Prediger, G. F. Passos et al., “Connecting TNF-α signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: relevance for the behavioral and synaptic deficits induced by amyloid β protein,” Journal of Neuroscience, vol. 27, no. 20, pp. 5394–5404, 2007. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Korkmaz, S. Rosales-Corral, and R. J. Reiter, “Gene regulation by melatonin linked to epigenetic phenomena,” Gene, vol. 503, no. 1, pp. 1–11, 2012. View at Publisher · View at Google Scholar · View at Scopus
  63. P. M. Martin, P. Roon, T. K. Van Ells, V. Ganapathy, and S. B. Smith, “Death of retinal neurons in streptozotocin-induced diabetic mice,” Investigative Ophthalmology and Visual Science, vol. 45, no. 9, pp. 3330–3336, 2004. View at Publisher · View at Google Scholar · View at Scopus
  64. J. H. Yang, H. W. Kwak, T. G. Kim, J. Han, S. W. Moon, and S. Y. Yu, “Retinal neurodegeneration in type II diabetic Otsuka long-evans Tokushima fatty rats,” Investigative Ophthalmology and Visual Science, vol. 54, no. 6, pp. 3844–3851, 2013. View at Publisher · View at Google Scholar · View at Scopus
  65. X. Li, M. Zhang, and W. Tang, “Effects of melatonin on streptozotocin-induced retina neuronal apoptosis in high blood glucose rat,” Neurochemical Research, vol. 38, no. 3, pp. 669–676, 2013. View at Publisher · View at Google Scholar · View at Scopus
  66. S. W. Park, H. S. Lee, M. S. Sung, and S. J. Kim, “The effect of melatonin on retinal ganglion cell survival in ischemic retina,” Chonnam Medical Journal, vol. 48, no. 2, pp. 116–122, 2012. View at Publisher · View at Google Scholar
  67. C. Yi, X. Pan, H. Yan, M. Guo, and W. Pierpaoli, “Effects of melatonin in age-related macular degeneration,” Annals of the New York Academy of Sciences, vol. 1057, pp. 384–392, 2005. View at Publisher · View at Google Scholar · View at Scopus